The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Anticoagulation Therapy-Global Market Insights and Sales Trends 2025
Synopsis
Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, blood transfusion bags, and dialysis equipment.
The global Anticoagulation Therapy market size is expected to reach US$ 43140 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Anticoagulation Therapy in various end use industries. The expanding demands from the Hospital Associated Clinics, Independent Clinics and Pharmacy-Based Clinics,, are propelling Anticoagulation Therapy market. NOACs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Warfarin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anticoagulation Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anticoagulation Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anticoagulation Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anticoagulation Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anticoagulation Therapy covered in this report include CH Boehringer Sohn, Bristol-Myers Squibb, Johnson＆Johnson, Pfizer, Daiichi Sankyo, Portola Pharmaceuticals, Roche and Abbott, etc.
The global Anticoagulation Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CH Boehringer Sohn
Bristol-Myers Squibb
Johnson＆Johnson
Pfizer
Daiichi Sankyo
Portola Pharmaceuticals
Roche
Abbott
Global Anticoagulation Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anticoagulation Therapy market, Segment by Type:
NOACs
Warfarin
Global Anticoagulation Therapy market, by Application
Hospital Associated Clinics
Independent Clinics
Pharmacy-Based Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anticoagulation Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, blood transfusion bags, and dialysis equipment.
The global Anticoagulation Therapy market size is expected to reach US$ 43140 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Anticoagulation Therapy in various end use industries. The expanding demands from the Hospital Associated Clinics, Independent Clinics and Pharmacy-Based Clinics,, are propelling Anticoagulation Therapy market. NOACs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Warfarin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anticoagulation Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anticoagulation Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anticoagulation Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anticoagulation Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anticoagulation Therapy covered in this report include CH Boehringer Sohn, Bristol-Myers Squibb, Johnson＆Johnson, Pfizer, Daiichi Sankyo, Portola Pharmaceuticals, Roche and Abbott, etc.
The global Anticoagulation Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
CH Boehringer Sohn
Bristol-Myers Squibb
Johnson＆Johnson
Pfizer
Daiichi Sankyo
Portola Pharmaceuticals
Roche
Abbott
Global Anticoagulation Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anticoagulation Therapy market, Segment by Type:
NOACs
Warfarin
Global Anticoagulation Therapy market, by Application
Hospital Associated Clinics
Independent Clinics
Pharmacy-Based Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Anticoagulation Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Anticoagulation Therapy
1.1 Anticoagulation Therapy Market Overview
1.1.1 Anticoagulation Therapy Product Scope
1.1.2 Anticoagulation Therapy Market Status and Outlook
1.2 Global Anticoagulation Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Anticoagulation Therapy Market Size by Region (2018-2029)
1.4 Global Anticoagulation Therapy Historic Market Size by Region (2018-2023)
1.5 Global Anticoagulation Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Anticoagulation Therapy Market Size (2018-2029)
1.6.1 North America Anticoagulation Therapy Market Size (2018-2029)
1.6.2 Europe Anticoagulation Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Anticoagulation Therapy Market Size (2018-2029)
1.6.4 Latin America Anticoagulation Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Anticoagulation Therapy Market Size (2018-2029)
2 Anticoagulation Therapy Market by Type
2.1 Introduction
2.1.1 NOACs
2.1.2 Warfarin
2.2 Global Anticoagulation Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Anticoagulation Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Anticoagulation Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Anticoagulation Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Anticoagulation Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Anticoagulation Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Anticoagulation Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Anticoagulation Therapy Revenue Breakdown by Type (2018-2029)
3 Anticoagulation Therapy Market Overview by Application
3.1 Introduction
3.1.1 Hospital Associated Clinics
3.1.2 Independent Clinics
3.1.3 Pharmacy-Based Clinics
3.2 Global Anticoagulation Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Anticoagulation Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Anticoagulation Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Anticoagulation Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Anticoagulation Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Anticoagulation Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Anticoagulation Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Anticoagulation Therapy Revenue Breakdown by Application (2018-2029)
4 Anticoagulation Therapy Competition Analysis by Players
4.1 Global Anticoagulation Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anticoagulation Therapy as of 2022)
4.3 Date of Key Players Enter into Anticoagulation Therapy Market
4.4 Global Top Players Anticoagulation Therapy Headquarters and Area Served
4.5 Key Players Anticoagulation Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Anticoagulation Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 CH Boehringer Sohn
5.1.1 CH Boehringer Sohn Profile
5.1.2 CH Boehringer Sohn Main Business
5.1.3 CH Boehringer Sohn Anticoagulation Therapy Products, Services and Solutions
5.1.4 CH Boehringer Sohn Anticoagulation Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 CH Boehringer Sohn Recent Developments
5.2 Bristol-Myers Squibb
5.2.1 Bristol-Myers Squibb Profile
5.2.2 Bristol-Myers Squibb Main Business
5.2.3 Bristol-Myers Squibb Anticoagulation Therapy Products, Services and Solutions
5.2.4 Bristol-Myers Squibb Anticoagulation Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Bristol-Myers Squibb Recent Developments
5.3 Johnson＆Johnson
5.3.1 Johnson＆Johnson Profile
5.3.2 Johnson＆Johnson Main Business
5.3.3 Johnson＆Johnson Anticoagulation Therapy Products, Services and Solutions
5.3.4 Johnson＆Johnson Anticoagulation Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Anticoagulation Therapy Products, Services and Solutions
5.4.4 Pfizer Anticoagulation Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Daiichi Sankyo
5.5.1 Daiichi Sankyo Profile
5.5.2 Daiichi Sankyo Main Business
5.5.3 Daiichi Sankyo Anticoagulation Therapy Products, Services and Solutions
5.5.4 Daiichi Sankyo Anticoagulation Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Daiichi Sankyo Recent Developments
5.6 Portola Pharmaceuticals
5.6.1 Portola Pharmaceuticals Profile
5.6.2 Portola Pharmaceuticals Main Business
5.6.3 Portola Pharmaceuticals Anticoagulation Therapy Products, Services and Solutions
5.6.4 Portola Pharmaceuticals Anticoagulation Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Portola Pharmaceuticals Recent Developments
5.7 Roche
5.7.1 Roche Profile
5.7.2 Roche Main Business
5.7.3 Roche Anticoagulation Therapy Products, Services and Solutions
5.7.4 Roche Anticoagulation Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 Roche Recent Developments
5.8 Abbott
5.8.1 Abbott Profile
5.8.2 Abbott Main Business
5.8.3 Abbott Anticoagulation Therapy Products, Services and Solutions
5.8.4 Abbott Anticoagulation Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Abbott Recent Developments
6 North America
6.1 North America Anticoagulation Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Anticoagulation Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulation Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Anticoagulation Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulation Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Anticoagulation Therapy Market Dynamics
11.1 Anticoagulation Therapy Industry Trends
11.2 Anticoagulation Therapy Market Drivers
11.3 Anticoagulation Therapy Market Challenges
11.4 Anticoagulation Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
